199 related articles for article (PubMed ID: 20704826)
1. [DNA methylation and non-small cell lung cancer].
Zhang Y; Chen L
Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):821-6. PubMed ID: 20704826
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer.
Liu S; Chen X; Chen R; Wang J; Zhu G; Jiang J; Wang H; Duan S; Huang J
Oncotarget; 2017 May; 8(22):36354-36367. PubMed ID: 28422739
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation in non-small cell lung cancer.
Suzuki M; Yoshino I
Surg Today; 2010 Jul; 40(7):602-7. PubMed ID: 20582509
[TBL] [Abstract][Full Text] [Related]
4. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic profiling of non-small cell lung cancer xenografts uncover LRP12 DNA methylation as predictive biomarker for carboplatin resistance.
Grasse S; Lienhard M; Frese S; Kerick M; Steinbach A; Grimm C; Hussong M; Rolff J; Becker M; Dreher F; Schirmer U; Boerno S; Ramisch A; Leschber G; Timmermann B; Grohé C; Lüders H; Vingron M; Fichtner I; Klein S; Odenthal M; Büttner R; Lehrach H; Sültmann H; Herwig R; Schweiger MR
Genome Med; 2018 Jul; 10(1):55. PubMed ID: 30029672
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
7. Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis.
Ren M; Wang C; Sheng D; Shi Y; Jin M; Xu S
Ann Diagn Pathol; 2017 Apr; 27():57-61. PubMed ID: 28325362
[No Abstract] [Full Text] [Related]
8. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
[TBL] [Abstract][Full Text] [Related]
9. A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.
Shen S; Zhang R; Guo Y; Loehrer E; Wei Y; Zhu Y; Yuan Q; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Su L; Chen F; Christiani DC
Mol Oncol; 2018 Jun; 12(6):913-924. PubMed ID: 29656435
[TBL] [Abstract][Full Text] [Related]
10. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L
Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiles of bronchoscopic biopsies for the diagnosis of lung cancer.
Goldmann T; Schmitt B; Müller J; Kröger M; Scheufele S; Marwitz S; Nitschkowski D; Schneider MA; Meister M; Muley T; Thomas M; Kugler C; Rabe KF; Siebert R; Reck M; Ammerpohl O
Clin Epigenetics; 2021 Feb; 13(1):38. PubMed ID: 33596996
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
13. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
14. [Research Advances of m⁶A RNA Methylation in Non-small Cell Lung Cancer].
Pan H; Li X; Chen C; Fan Y; Zhou Q
Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):961-969. PubMed ID: 33203198
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Role of RASSF1A and p16INK4a Promoter Gene Hypermethylation in Serum DNA of Lung Cancer Patients: Clinicopathological Significance.
El-Sherif WT; Sayed SK; Galal SH; Makhlouf HA; Hassan AT; Yousef HA
Egypt J Immunol; 2016 Jun; 23(2):1-16. PubMed ID: 28502129
[TBL] [Abstract][Full Text] [Related]
16. Global methylation profiling of lung cancer identifies novel methylated genes.
Dai Z; Lakshmanan RR; Zhu WG; Smiraglia DJ; Rush LJ; Frühwald MC; Brena RM; Li B; Wright FA; Ross P; Otterson GA; Plass C
Neoplasia; 2001; 3(4):314-23. PubMed ID: 11571631
[TBL] [Abstract][Full Text] [Related]
17. The role of prognostic factors and oncogenes in the detection and management of non-small-cell lung cancer.
Van Zandwijk N; Van 't Veer LJ
Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):55-9. PubMed ID: 9516613
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
[TBL] [Abstract][Full Text] [Related]
19. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
[TBL] [Abstract][Full Text] [Related]
20. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history.
Eguchi K; Kanai Y; Kobayashi K; Hirohashi S
Cancer Res; 1997 Nov; 57(21):4913-5. PubMed ID: 9354457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]